10% 🎁 CODE: FireBar10

FireBar Labs

same day ✈️ order before 3pm

FireBar Labs

📦 all in-stock items ship same day m-f

FireBar Labs

Cannabis has played an unexpected and often overlooked role in American history, from the colonial period through the 21st century. Understanding how cannabis evolved from a staple agricultural crop to a controlled substance—and now back toward legalization—provides crucial context for today's hemp and cannabis landscape. This evolution wasn't inevitable; it was shaped by politics, race, economics, and shifting scientific understanding.

Hemp in Colonial America: A Cash Crop and Economic Necessity

Cannabis sativa, commonly known as hemp, arrived in North America with the earliest European colonists. In the 1600s and 1700s, hemp was far more valuable for its fiber than any psychoactive properties. Colonial farmers grew hemp for rope, sails, textiles, and paper—essential materials for a young nation building ships and establishing trade.

Virginia, Pennsylvania, and other colonies actively encouraged hemp cultivation. Some colonial governments even required farmers to grow hemp as part of tax obligations. The plant thrived in North American soil, and hemp fiber became a cornerstone of the colonial economy. George Washington and Thomas Jefferson both grew hemp on their plantations, though historical records show their focus was fiber production, not intoxication.

By the time of the American Revolution, hemp was so economically important that the founding fathers recognized it as a strategic resource. Early American currency and documents were printed on hemp paper, cementing the plant's status as a foundational crop for the new nation.

The 19th Century: Industrial Hemp and Early Medical Cannabis

Throughout the 1800s, hemp production remained strong, but the invention of the cotton gin and other machinery gradually shifted agricultural priorities. However, cannabis itself—specifically cannabis extracts—entered American medicine during this era. By the mid-1800s, cannabis tinctures appeared in medical pharmacies and were used by physicians to treat pain, inflammation, nausea, and other ailments.

Medical journals of the era published research on cannabis therapeutics. One prominent physician, William O'Shaughnessy, brought cannabis medicine from India to America, where it gained credibility in mainstream medical practice. From roughly 1850 to 1930, cannabis-based medicines were legal, regulated, and widely available in American pharmacies.

Recreational cannabis use existed but was largely associated with certain immigrant communities and remained relatively uncommon in mainstream American culture. The plant occupied dual roles: industrial hemp for fiber and textiles, and medical cannabis for therapeutic purposes.

The Turn of the Century: The Beginning of Prohibition

The early 1900s marked the beginning of cannabis's transformation from legal commodity to restricted substance. Several factors converged: growing anti-immigrant sentiment, particularly toward Mexican and Chinese populations; the rise of pharmaceutical companies that saw cannabis as competition; and a broader "drug panic" movement sweeping through American society.

Marijuana—a term derived from Spanish that emphasized the plant's association with Mexican immigrants—became increasingly demonized in political and media narratives. Anti-cannabis sentiment was often intertwined with racist attitudes toward Latino and Black communities, particularly in the American South and Southwest where Mexican immigrants worked in agriculture and mining.

By 1914, many states had passed their own cannabis restrictions. The Federal Bureau of Narcotics, established in 1930 under Commissioner Harry J. Anslinger, launched an aggressive campaign against marijuana. Anslinger leveraged racial fears, exaggerated claims about marijuana's dangers, and political pressure to build support for federal prohibition. His famous "marihuana madness" campaigns associated the drug with crime, violence, and moral degradation—claims later recognized as fabricated and racially motivated.

The Marijuana Tax Act and Federal Prohibition (1937)

On August 2, 1937, President Franklin D. Roosevelt signed the Marihuana Tax Act into law. Technically, the act didn't outright ban cannabis; instead, it imposed a prohibitive tax and licensing requirements that made possession and cultivation economically impractical. The law was effective in eliminating both recreational and medical cannabis markets.

Hemp cultivation also suffered. Although industrial hemp (low-THC varieties) could theoretically be grown under the tax framework, the regulatory burden and cultural stigma made hemp farming economically unfeasible. American hemp production virtually ceased, and the nation became dependent on imported hemp fiber.

The 1937 prohibition occurred without robust scientific debate or medical consensus. In fact, the American Medical Association (AMA) opposed the tax act, arguing that cannabis had legitimate medical uses. Their objections were overridden by political momentum and Anslinger's influence.

Mid-20th Century: Escalation and the War on Drugs

From the 1930s through the 1960s, cannabis remained federally illegal and increasingly criminalized at state and local levels. Penalties escalated dramatically during the 1970s under President Richard Nixon's "War on Drugs." The Controlled Substances Act of 1970 placed cannabis in Schedule I—the most restrictive category—alongside heroin and LSD, asserting it had no accepted medical use and high abuse potential.

This classification contradicted emerging scientific research showing cannabis's therapeutic potential for pain, epilepsy, nausea, and other conditions. Nonetheless, federal policy remained rigid. Arrest rates for cannabis possession skyrocketed, disproportionately affecting Black and Latino Americans despite similar usage rates across racial groups.

Underground cannabis culture flourished, particularly during the 1960s and 1970s counterculture movement. Despite prohibition, casual use became more common among younger Americans, and medical researchers continued investigating cannabis's therapeutic properties—though federal restrictions on research made such studies difficult to conduct.

The Modern Movement: Medical Legalization and Decriminalization (1990s–2010s)

California's passage of Proposition 215 in 1996 marked a turning point. The Compassionate Use Act legalized medical cannabis for patients with chronic pain, cancer, AIDS, and other conditions. Despite federal prohibition, California's law created the first legal medical cannabis market in decades.

Other states followed suit. By the early 2020s, 38 states had legalized medical cannabis, creating a legal landscape that directly contradicted federal law. Simultaneously, several states—beginning with Colorado and Washington in 2012—legalized recreational cannabis for adults. This wave of state legalization reflected changing public opinion: by 2026, polling showed roughly 70% of Americans supported cannabis legalization for medical purposes.

The conflict between state and federal law created practical and banking challenges. Cannabis businesses operated in legal gray zones, unable to access federal banking services or tax deductions. Nonetheless, the legal cannabis market grew to billions of dollars annually.

In parallel, industrial hemp experienced a renaissance. The 2018 Farm Bill, signed by President Trump, removed hemp (defined as cannabis with less than 0.3% delta-9 THC) from federal drug enforcement. This law opened the door for domestic hemp cultivation and hemp-derived products like CBD, which exploded in popularity as a wellness supplement.

2026 and Beyond: The Path Forward

By 2026, the legal landscape for cannabis in America has become increasingly complex and fragmented. The 2026 Farm Bill continues refining hemp regulations, with new total-THC measurement standards designed to close loopholes and ensure compliance. Hemp-derived edibles and other products remain legal federally provided they meet strict THC thresholds.

Public opinion continues moving toward normalization. Many states are exploring cannabis legalization; others are expunging past cannabis convictions. Medical research into cannabis's therapeutic potential has expanded, with studies documenting benefits for chronic pain, epilepsy, and other conditions.

However, federal prohibition persists despite state-level legalization and growing medical evidence. This creates ongoing challenges for cannabis businesses, researchers, and patients. The federal scheduling of cannabis remains one of the most contentious drug policy debates in America.

Why History Matters

Understanding cannabis history is essential for informed policy conversations. The 1937 prohibition wasn't based on scientific evidence or public health data—it emerged from racist political campaigns and economic interests. The 80-year criminalization that followed caused incalculable harm: millions of arrests, broken families, incarceration, and disproportionate impacts on communities of color.

Today's cannabis legalization movement represents, in part, a reckoning with this history. Many legalization advocates argue that past policy failures demand policy reform, expungement of prior cannabis convictions, and equitable access to the legal cannabis market.

For consumers navigating the modern cannabis and hemp landscape, historical context matters. It helps explain why federal law still restricts what scientists and patients have come to view as a legitimate therapeutic agent. It contextualizes the social and racial justice dimensions of drug policy. And it reminds us that law and science don't always align—and that public health policy should be evidence-based, not fear-based.

FAQs

Did the founding fathers use cannabis recreationally?

Historical records show that George Washington and Thomas Jefferson grew hemp on their plantations, but evidence suggests their focus was fiber production for economic purposes, not recreational use. Cannabis's psychoactive properties were not a major cultural focus in colonial America.

Why was cannabis made illegal in 1937?

The 1937 Marihuana Tax Act resulted from political campaigns that exaggerated cannabis's dangers, anti-immigrant sentiment (particularly toward Mexicans and Chinese), economic interests from pharmaceutical companies, and the influence of Federal Bureau of Narcotics Commissioner Harry J. Anslinger. Scientific and medical evidence did not support prohibition.

When did medical cannabis become legal?

California legalized medical cannabis in 1996 with Proposition 215. Following that, other states gradually passed medical cannabis laws. By 2026, 38 states have legalized medical cannabis, though it remains federally illegal.

What is the 2018 Farm Bill and how did it change hemp?

The 2018 Farm Bill removed hemp (cannabis with less than 0.3% delta-9 THC) from federal drug scheduling, allowing domestic hemp cultivation and legal hemp-derived products like CBD. This law revived hemp as an agricultural commodity after decades of prohibition.

Is cannabis still illegal federally in 2026?

Yes. Cannabis remains classified as Schedule I under the Controlled Substances Act, meaning federal law prohibits it despite legalization in many states. However, hemp-derived products meeting federal THC thresholds are legal.

Explore FireBar Labs

Questions? Email support@firebarlabs.com — we respond within 24 hours.

FireBar Labs Insider

Get hemp science & state-law updates in your inbox.

Plain-English explainers, compliance alerts, and early access to new products. No spam — unsubscribe anytime.